Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
colorectal cancer
Biotech
Leap expands layoffs to 75% of staff, scraps last clinical trial
Leap Therapeutics is expanding its layoff plans to encompass three-quarters of its staff while scrapping its sole clinical trial.
James Waldron
Jun 23, 2025 9:22am
Exelixis beats Bayer drug in cancer trial, sending stock higher
Jun 23, 2025 7:30am
Leap halves head count amid 'difficult market environment'
May 13, 2025 9:10am
Exact Sciences kicks off launch of next-gen Cologuard Plus test
Mar 31, 2025 6:00am
Leap crashes as midphase data mark end of gastric cancer program
Jan 28, 2025 8:31am
JPM25: Guardant posts 31% sales gain as cancer blood tests grow
Jan 13, 2025 9:19am
